本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

達維塔保健

129.55
+0.36000.28%
盤後129.560.0100+0.01%16:52 EDT
成交量:54.20萬
成交額:7,013.27萬
市值:92.63億
市盈率:12.71
高:129.77
開:129.17
低:128.69
收:129.19
52周最高:179.60
52周最低:122.93
股本:7,150.00萬
流通股本:3,816.14萬
量比:1.00
換手率:1.42%
股息:- -
股息率:- -
每股收益(TTM):10.20
每股收益(LYR):11.02
淨資產收益率:57.94%
總資產收益率:7.15%
市淨率:-25.06
市盈率(LYR):11.76

資料載入中...

2024/05/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/02

重要事件披露

Form 8-K - Current report
2024/05/01

重要事件披露

Form 8-K - Current report
2024/04/10

重要事件披露

Form 8-K - Current report
2024/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/16

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/15

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

重要事件披露

Form 8-K - Current report
2023/11/07

重要事件披露

Form 8-K - Current report
2023/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/03

重要事件披露

Form 8-K - Current report
2023/08/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/25

重要事件披露

Form 8-K - Current report